Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions
Authors:
- Joachim T SiawJSJoachim T Siaw
- Peter MerseburgerPMPeter Merseburger
- Marcus BorenäsMBMarcus Borenäs
- Caroline JanssonCJCaroline Jansson
- Jenny KarlssonJKJenny Karlsson
- Arne ClaeysACArne Claeys
- Eva JennischeEJEva Jennische
- Dan E LindDLDan E Lind
- David Gisselsson NordDNDavid Gisselsson Nord
- Ruth H PalmerRPRuth H Palmer
- Jimmy Van Den EyndenJEJimmy Van Den Eynden
Open Access
- 8 August 2025
- journal article
- Published by Wiley in The Journal of Pathology
- Vol. 267 (2) , 181-195
Abstract
High‐risk neuroblastomas exhibit a high degree of intratumoral heterogeneity. Single‐cell RNA sequencing has greatly improved our understanding of these tumors, but the method lacks cellular tissue context and spatial information about local signaling dynamics. To address this, we profiled untreated and chemotherapy‐treated high‐risk neuroblastomas from archived, formalin‐fixed, paraffin‐embedded (FFPE) tissues from two patients using spatial transcriptomics. We confirmed the transcriptional and cellular heterogeneous nature of the neuroblastoma microenvironment and identified several unique spatial niches and patterns. In one of the treated tumors, a spatially constrained cluster of undifferentiated and 11p‐gained cancer cells was identified, surrounded by a rim of macrophages. A signaling interaction between the chemokine CCL18 and its receptor PITPNM3 was predicted between these cells. In the other tumor, we identified a stromal cluster with high transcriptional similarity to the adrenal cortex. These adrenocortical‐like cells expressed several oncogenic ligand‐encoding genes (e.g. ALKAL2 and NRTN), which were predicted to communicate with neighboring cancer cells that expressed the corresponding receptors (e.g. ALK, RET). Several of these interactions were further validated experimentally and were shown to be clinically relevant. Collectively, our spatial analysis identifies multiple previously unrecognized signaling axes that may offer novel therapeutic options in neuroblastoma. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- Cancerfonden (21 1383 Pj, CAN21/1459)
- Stiftelsen Assar Gabrielssons Fond (FB23‐92)
- Barncancerfonden (PR2022‐0026, PR2022‐0029, TJ2021‐0068)
- Stichting Tegen Kanker (STI.STK.2023.0017)
- Fonds Wetenschappelijk Onderzoek (FWO.3F0.2024.0075, FWO.OPR.2023.0063)
- Science for Life Laboratory
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Uppsala Multidisciplinary Center for Advanced Computational Science
This publication has 59 references indexed in Scilit:
- NBAtlas: A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumorsCell Reports, 2024
- Evolutionary switch in expression of key markers between mouse and human leads to mis-assignment of cell types in developing adrenal medullaCancer Cell, 2021
- UCell: Robust and scalable single-cell gene signature scoringComputational and Structural Biotechnology Journal, 2021
- Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal NeuroblastomaCancer Cell, 2020
- Validation of the Oncomine™ focus panel for next-generation sequencing of clinical tumour samplesVirchows Archiv, 2018
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in NeuroblastomaCancer Cell, 2012
- CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3Cancer Cell, 2011
- Neuroblastoma: Biology, Prognosis, and TreatmentHematology/Oncology Clinics of North America, 2010
- The role of GDNF family ligand signalling in the differentiation of sympathetic and dorsal root ganglion neuronsCell and tissue research, 2008